• FY26 revenue expected to be $105-115 million
• Reported EBITDA expected to be -$2m to +$2m
• Underlying EBITDA expected to be $4-8 million
• Expansion in the USA and positive FDA engagement
• Strong balance sheet and liquidity

Bubs Australia Ltd has provided a trading update for its unaudited financial results for FY26. The company expects revenue to be between $105 million and $115 million, demonstrating underlying growth despite challenging external market conditions. Reported EBITDA is expected to be between -$2 million and +$2 million, with underlying EBITDA expected to be between $4 million and $8 million. Sales and earnings have been impacted by evolving regulatory requirements, product availability constraints, geopolitical disruptions, increased air freight costs, and competitive pressures. The company has taken action to mitigate these impacts and continues to deliver underlying growth. Engagement with the FDA remains positive, with the review progressing to its final stages.

FY26 revenue expected to be $105-115 million, EBITDA -$2m to +$2m, underlying EBITDA $4-8 million

Bubs Australia Ltd remains focused on converting demand into sustainable growth by expanding distribution and investing in brand activation and strategic initiatives.